6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

6 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02438215 (ClinicalTrials.gov)	August 2014	7/8/2014	Study of IRX4204 for Treatment of Early Parkinson's Disease	An Open-Label, Single Site Study Using [123I]ß-CIT Single Photon Emission Tomography (SPECT) to Evaluate Dopamine Transporter Binding Following Treatment With IRX4204 in Early Parkinson's Disease Subjects	Parkinson's Disease	Drug: IRX4204	Io Therapeutics	NULL	Completed	18 Years	N/A	Both	15	Phase 1	United States
2	NCT00387075 (ClinicalTrials.gov)	November 2006	10/10/2006	A Study Evaluating Potential Screening Tools for Detecting Parkinson Disease	Parkinson Associated Risk Factor Study (PARS): Evaluating Potential Screening Tools for Parkinson Disease	Parkinson Disease	Procedure: [123I]ß-CIT and SPECT imaging;Drug: [123I]ß-CIT	Institute for Neurodegenerative Disorders	United States Department of Defense;Molecular NeuroImaging	Active, not recruiting	50 Years	N/A	All	3000	Phase 2	United States
3	NCT00315250 (ClinicalTrials.gov)	January 2006	14/4/2006	Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease	Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease	Parkinson's Disease;Parkinsonian Syndrome	Drug: [123I]ß-CIT	Institute for Neurodegenerative Disorders	Department of Defense;Molecular NeuroImaging	Completed	22 Years	N/A	Both	225	Phase 2	United States
4	NCT00096720 (ClinicalTrials.gov)	February 2004	12/11/2004	Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease	Investigating Effects of Short-term Treatment With Pramipexole or Levodopa on [123I]B-CIT and SPECT Imaging in Early Parkinson's	Parkinson Disease;Parkinsonian Syndrome	Drug: levodopa;Drug: Mirapex (pramipexole);Procedure: [123I]ß-CIT and SPECT imaging	Institute for Neurodegenerative Disorders	Boehringer Ingelheim;Department of Defense	Completed	30 Years	N/A	Both	112	Phase 2	United States
5	NCT00134784 (ClinicalTrials.gov)	April 2000	23/8/2005	Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression	[123I]ß-CIT and SPECT in Vivo Three Year Imaging Assessment of Dopamine Transporter Density in Subjects With Early Parkinson's Disease Participating in Earlier vs. Later Levodopa in Parkinson's Disease	Parkinson Disease	Drug: [123I]B-CIT SPECT imaging	Institute for Neurodegenerative Disorders	United States Department of Defense	Completed	22 Years	N/A	All	142	Phase 2	NULL
6	NCT00132626 (ClinicalTrials.gov)	September 1992	18/8/2005	Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome	Dynamic SPECT Imaging With [123I]ß-CIT in Patients With Parkinsonism	Parkinson's Disease;Parkinsonian Syndrome	Drug: [123I]ß-CIT and SPECT imaging	Institute for Neurodegenerative Disorders	Molecular NeuroImaging;National Institutes of Health (NIH)	Completed	35 Years	N/A	All	500	Phase 2	NULL

先頭へ